Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)

NCT04882228 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Venous Disease

Interventions

DRUG: Entelon Tab.150mg
DRUG: Venitol Tab.
DRUG: Placebo of Venitol Tab.
DRUG: Placebo of Entelon Tab.150mg

Sponsor

Hanlim Pharm. Co., Ltd.